SCHEMBL20288512

SCHEMBL20288512

CC(=O)Nc1cccc(-c2ccc3c(c2)[C@H](Nc2ccc(N)cc2Cl)C[C@H](C)N3C(C)=O)c1

nearest known ligand 0.65

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 20/20 0.65
▸ BRD2 P25440 19/20 0.65
▸ BRD3 Q15059 18/20 0.60
▸ CYP3A4 P08684 2/20 0.52
▸ CYP2C9 P11712 2/20 0.52
▸ CYP2C19 P33261 2/20 0.52
▸ TRIM24 O15164 1/20 0.52
▸ TAF1 P21675 1/20 0.52
▸ EP300 Q09472 1/20 0.52
▸ BRDT Q58F21 1/20 0.52
▸ PBRM1 Q86U86 1/20 0.52
▸ TAF1L Q8IZX4 1/20 0.52
▸ CREBBP Q92793 1/20 0.52
▸ BRWD1 Q9NSI6 1/20 0.52
▸ TRIM33 Q9UPN9 1/20 0.52
▸ CYP2D6 P10635 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20288509 0.91 BRD4 (0.65) BRD4BRD2BRD3CYP3A4CYP2C9
SCHEMBL26487330 0.91 BRD4 (0.65) BRD4BRD2BRD3CYP3A4CYP2C9
SCHEMBL20288510 0.91 BRD4 (0.64) BRD4BRD2BRD3CYP3A4CYP2C9
SCHEMBL20288494 0.90 BRD4 (0.68) BRD4BRD2BRD3CYP3A4CYP2C9
SCHEMBL20288484 0.90 BRD4 (0.68) BRD4BRD2BRD3CYP3A4CYP2C9
SCHEMBL23467422 0.88 BRD4 (0.65) BRD4BRD2BRD3CYP3A4CYP2C9
SCHEMBL26487317 0.88 BRD4 (0.62) BRD4BRD2BRD3CYP3A4CYP2C9
SCHEMBL20288485 0.87 BRD4 (0.68) BRD4BRD2BRD3CYP3A4CYP2C9
SCHEMBL20288487 0.86 BRD4 (0.70) BRD4BRD2BRD3CYP3A4CYP2C9
SCHEMBL20270648 0.85 BRD4 (0.79) BRD4BRD2BRD3CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018111805-A1 TETRAHYDROQUINOLINE-BASED BROMODOMAIN INHIBITORS ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) 2018-06-21 — — WO disclosed
Send feedback